ProRx Pharma triples production capacity

ProRx Pharma, a leading 503B outsourcing facility, is experiencing significant growth, marked by a tripling of its production capacity. This expansion is driven by increasing demand for its compounded medications. The company's enhanced operational footprint and increased output will enable it to better serve its clients and meet market needs. This strategic move underscores ProRx Pharma's commitment to scaling its services and supporting the healthcare sector.